This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Niall Morrisson Barr Martin: Innovator in Medicinal Chemistry
Introduction
Niall Morrisson Barr Martin is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for therapeutic use. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Niall holds a patent for a compound of formula I, which includes pharmaceutically acceptable salts. This compound is notable for its potential use as a medicament in the treatment of cancer. The patent also outlines processes for the manufacture of this compound, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Niall has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Kudos Pharmaceuticals Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.
Collaborations
Niall has collaborated with several talented individuals in his field, including Heather Mary Ellen Duggan and Karine Malagu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Niall Morrisson Barr Martin is a notable figure in the realm of medicinal chemistry, with a focus on developing compounds that can significantly impact cancer treatment. His work exemplifies the importance of innovation in healthcare and the ongoing pursuit of effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
